COL Financial Group, Inc. (PSE:COL)

Achilles Therapeutics Ratios and Metrics

Market cap in millions PHP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,044	9,817	12,662	15,280	19,754	16,184
Market Cap Growth	-13.76%	-22.46%	-17.13%	-22.65%	22.06%	84.58%
Last Close Price	1.52	1.59	2.00	2.38	3.00	2.42
PE Ratio	18.04	20.19	29.68	62.61	33.87	38.14
PS Ratio	7.68	8.25	11.66	18.39	14.98	15.02
PB Ratio	3.61	4.16	5.78	7.74	9.41	8.85
P/FCF Ratio	-	27.81	-	45.26	-	4.45
P/OCF Ratio	-	26.51	-	42.31	-	4.43
Debt / Equity Ratio	0.01	0.01	0.02	0.03	0.02	0.02
Debt / FCF Ratio	-	0.08	-	0.15	-	0.01
Asset Turnover	0.09	0.10	0.09	0.06	0.10	0.09
Quick Ratio	1.11	1.09	1.05	1.08	0.27	0.58
Current Ratio	1.11	1.09	1.07	1.08	0.27	0.59
Return on Equity (ROE)	20.81%	21.32%	20.43%	11.89%	29.61%	23.62%
Return on Assets (ROA)	3.98%	3.92%	3.35%	1.86%	4.36%	3.54%
Earnings Yield	5.54%	4.95%	3.37%	1.60%	2.95%	2.62%
FCF Yield	-3.74%	3.60%	-1.38%	2.21%	-1.20%	22.47%
Dividend Yield	3.62%	0.98%	0.75%	0.38%	0.64%	0.66%
Payout Ratio	17.66%	18.21%	12.72%	46.81%	53.05%	20.19%
Total Shareholder Return	3.62%	0.98%	0.75%	0.38%	0.64%	0.66%

Updated Nov 18, 2024. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.